Rheumatology

With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…

Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…

Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…

Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases

Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a breakdown in immune tolerance

Autoimmune responses need to be identified and managed promptly to avoid deleterious consequences. Autoimmune diseases, such as rheumatoid arthritis (RA)…

This review analyses the factors responsible for higher ischaemic and haemorrhagic stroke risk in the systemic lupus erythematosus population

Objectives: To examine the combined effectiveness of a care pathway for patients with suspected inflammatory back pain (IBP) in conjunction with an…